91 related articles for article (PubMed ID: 7537898)
41. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
Zanetta G; Fei F; Mangioni C
Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
[TBL] [Abstract][Full Text] [Related]
42. Gynecologic malignancies.
Schilder RJ; Scher RM; Young RC
Cancer Chemother Biol Response Modif; 1993; 14():530-56. PubMed ID: 8312118
[TBL] [Abstract][Full Text] [Related]
43. Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy.
Lai CH; Hsueh S; Chang TC; Tseng CJ; Huang KG; Chou HH; Chen SM; Chang MF; Shum HC
Gynecol Oncol; 1997 Mar; 64(3):456-62. PubMed ID: 9062150
[TBL] [Abstract][Full Text] [Related]
44. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
45. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
[TBL] [Abstract][Full Text] [Related]
46. [Chemotherapy of carcinoma of the cervix uteri. Current approaches].
Sesti F; Mantenuto L; Ciancaglini G; Araco P; De Santis L; Piccione E
G Ital Oncol; 1989; 9(4):125-8. PubMed ID: 2693349
[TBL] [Abstract][Full Text] [Related]
47. Locally advanced cervical cancer: what is the standard of care?
Al-Mansour Z; Verschraegen C
Curr Opin Oncol; 2010 Sep; 22(5):503-12. PubMed ID: 20473164
[TBL] [Abstract][Full Text] [Related]
48. Further experience with hexamethylmelamine (NSC-13875) in the treatment of carcinoma of the cervix.
Stolinsky DC; Bateman JR
Cancer Chemother Rep; 1973; 57(4):497-9. PubMed ID: 4586957
[No Abstract] [Full Text] [Related]
49. [Response evaluation criteria in chemotherapy for cervix neoplasm].
Hamada H; Tateyama I
Nihon Rinsho; 2004 Oct; 62 Suppl 10():205-8. PubMed ID: 15535235
[No Abstract] [Full Text] [Related]
50. The combination of cisplatin and topotecan as a second-line treatment for patients with advanced/recurrent uterine cervix cancer.
Moon JY; Song IC; Ko YB; Lee HJ
Medicine (Baltimore); 2018 Apr; 97(14):e0340. PubMed ID: 29620661
[TBL] [Abstract][Full Text] [Related]
51. Syzygium cumini inhibits growth and induces apoptosis in cervical cancer cell lines: a primary study.
Barh D; Viswanathan G
Ecancermedicalscience; 2008; 2():83. PubMed ID: 22275971
[TBL] [Abstract][Full Text] [Related]
52. Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study.
Garcia AA; Blessing JA; Darcy KM; Lenz HJ; Zhang W; Hannigan E; Moore DH
Gynecol Oncol; 2007 Mar; 104(3):572-9. PubMed ID: 17049588
[TBL] [Abstract][Full Text] [Related]
53. Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix.
Symonds P; Kirwan J; Williams C; Humber C; Tierney J; Green J; Collingwood M
Cochrane Database Syst Rev; 2004; 2004(1):CD003918. PubMed ID: 14974044
[TBL] [Abstract][Full Text] [Related]
54. The role of ifosfamide and systemic therapy in the management of carcinoma of the cervix.
Thigpen T; Vance R; Khansur T; Malamud F
Semin Oncol; 1996 Jun; 23(3 Suppl 6):56-64. PubMed ID: 8677451
[TBL] [Abstract][Full Text] [Related]
55. The role of paclitaxel in the management of patients with carcinoma of the cervix.
Thigpen T; Vance R; Khansur T; Malamud F
Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-41-S2-46. PubMed ID: 9045336
[TBL] [Abstract][Full Text] [Related]
56. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
57. [Standards, options and recommendations: concomitant radiochemotherapy for cancer of the cervix: a critical analysis of the literature and update of SOR].
Haie-Meder C; Fervers B; Chauvergne J; Fondrinier E; Lhommé C; Guastalla JP; Resbeut M
Bull Cancer; 1999 Oct; 86(10):829-41. PubMed ID: 10572234
[TBL] [Abstract][Full Text] [Related]
58. Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecologic Oncology Group.
Stehman FB; Bundy BN; Kucera PR; Deppe G; Reddy S; O'Connor DM
Gynecol Oncol; 1997 Aug; 66(2):262-7. PubMed ID: 9264574
[TBL] [Abstract][Full Text] [Related]
59. Chemotherapy as a palliative treatment in carcinoma of the uterine cervix.
Thigpen JT; Vance R; Puneky L; Khansur T
Semin Oncol; 1995 Apr; 22(2 Suppl 3):16-24. PubMed ID: 7537898
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
